Charles River is pleased to support our partner, Distributed Bio at the annual Antibody Engineering & Therapeutics conference. This year’s virtual event will take place on a dynamic interactive platform where you’ll find the latest science, technology and partners in antibody engineering, immunobiology, and next generation binders.
Don’t miss a presentation by Jake Glanville and Katherine Vousden on Monday, December 14, 3:15-3:45 EST. Rapid Discovery of Antibodies to Integral Membrane Proteins: A CXCR5 Seven Transmembrane Receptor Case Study will use functional data on CXCR5 activity to discuss how to avoid low expression level, difficult extraction, misfolding, and incomplete post-translational modifications
Together with Distributed Bio, Charles River offers an unmatched platform for integrated antibody discovery and development, empowering clients with the ability to identify, analyze, and engineer exclusive antibodies against even the most challenging targets.
Want to set aside time to chat with our scientists? Fill out the form to request a virtual consultation.